Bilal F. Hamzeh

Mr. Bilal F. Hamzeh

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EHEvan J. Haas
Evan J. Haas
BHBilal F. Hamzeh
Bilal F. Hamzeh
ZAZain Aryanpour
Zain Aryanpour
JYJason W. Yu
Jason W. Yu
DMDavid Mathes
David Mathes
CKChristodoulos Kaoutzanis
Christodoulos Kaoutzanis
Background and Objectives: Breast reconstruction after mastectomy has been shown to significantly improve psychosocial wellbeing and quality of life. Enhanced Recovery After Surgery (ERAS) protocols, especially those tailored to breast reconstruction, have revolutionized recovery by reducing complications, pain, opioid use, and hospital stay while improving patient satisfaction. The purpose of this narrative review was to present existing practices and supporting evidence within current ERAS protocols, as well as propose a modern ERAS framework centered around enhancing the patient experience following breast reconstruction. Methods: A focused literature search was conducted to identify studies investigating emerging approaches to patient care and surgical techniques adopted as part of a broader ERAS workflow Results: Some recent innovations include digital ERAS tracking, robot-assisted techniques, neurotization, and closed incision negative pressure therapy (ciNPT). These innovations show promise in reducing morbidity following reconstruction and may greatly improve sensory and functional outcomes. These advancements also reflect a shift toward more holistic, patient-centered care, extending beyond immediate clinical needs to address long-term wellbeing through psychosocial support and patient-reported outcome measures. Incorporating tools that validate patient perspectives helps guide interventions to optimize satisfaction and recovery. Conclusions: Future research should aim to standardize ERAS protocols by incorporating evidence-based practices, reinforcing breast reconstruction as a patient-centered, evidence-driven process that is focused on comprehensive recovery and improved quality of life.

20 October 2025 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
BHBilal F. Hamzeh
Bilal F. Hamzeh
ALAnna D. Lee
Anna D. Lee
BFBrooke French
Brooke French
PNPhuong Nguyen
Phuong Nguyen
JYJason W. Yu
Jason W. Yu
DKDavid Y. Khechoyan
David Y. Khechoyan
Orthognathic surgery requires precise manipulation of skeletal structures in close proximity to highly sensitive nerve, vascular, and airway anatomy. Rare iatrogenic injuries including hemorrhage and neurovascular compromise are reported and can have devastating sequelae including stroke, blindness, and death. Established technologies have primarily focused on positional accuracy rather than enhancing patient safety. This review investigates the adoption of intraoperative navigation in orthognathic surgery to reduce the risk of iatrogenic complications. Following PRISMA guidelines, a systematic search of PubMed, Embase, Web of Science, and Cochrane Library was conducted to identify original studies reporting on the application and outcomes of intraoperative navigation in orthognathic surgery. Data were extracted on indications, surgical procedures, navigation technologies, primary purpose for use, and outcomes. Thirty studies met inclusion criteria, and most were published after 2015 (63.3%). The majority (96.7%) used navigation to enhance accuracy of skeletal segment positioning; only 6.7% of studies reported use of intraoperative navigation to identify and avoid critical anatomic structures. BrainLab systems were most frequently used (40.0%), followed by Stryker (13.3%) and Aurora/Northern Digital Inc. (10.0%). Extensive evidence across multiple surgical specialties validates the efficacy of intraoperative navigation in reducing injury to critical structures and in limiting blood loss, operative time, and reoperation rates. Current literature supports intraoperative navigation as a highly accurate modality for orthognathic surgery but rarely addresses its potential to mitigate severe iatrogenic complications. Evidence from other surgical disciplines substantiates its role in enhancing safety, underscoring the need for high-level studies focused on complication prevention in orthognathic surgery.

8 February 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DSDaniel P. Salem
Daniel P. Salem
LBLaura T. Bortolin
Laura T. Bortolin
DGDan Gusenleitner
Dan Gusenleitner
JGJonian Grosha
Jonian Grosha
IZIbukun Zabroski
Ibukun Zabroski
JSJoseph C. Sedlak
Joseph C. Sedlak
Detection of cancer early, when it is most treatable, remains a significant challenge due to the lack of diagnostic methods sufficiently sensitive to detect nascent tumors. Early-stage tumors are small relative to their tissue of origin, heterogeneous, and infrequently manifest in clinical symptoms. Detection of their presence is made more difficult by a lack of abundant tumor-specific indicators (i.e., protein biomarkers, circulating tumor DNA, etc.) that would enable detection using a non-invasive diagnostic assay. In addition, many benign conditions manifest in a similar manner, thus discriminating an early-stage cancerous lesion from a benign tumor can present additional challenges and result in unnecessary medical procedures. To overcome these obstacles, we have developed a liquid biopsy assay that interrogates circulating extracellular vesicles (EVs) to detect tumor-specific biomarkers colocalized on the surface of individual EVs. Extracellular vesicles from all cell types, including early-stage tumors, are known to be abundant in blood, are remarkably stable, and serve as a biopsy of their cell of origin. The detection of a colocalized combination of cancer associated biomarkers that provide tumor specificity on the surface of extracellular vesicles enables the discrimination of early- and late-stage cancer from non-malignant conditions.

Verified
Journal Article
Open access
PDF file
BHBilal F. Hamzeh
Bilal F. Hamzeh
COChristopher Orear
Christopher Orear
MMMarkos Mardourian
Markos Mardourian
CKCarson Keeter
Carson Keeter
KEKatie Egan
Katie Egan
CKChristodoulos Kaoutzanis
Christodoulos Kaoutzanis
Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly prescribed for diabetes and weight loss, with many breast reconstruction candidates being prescribed these medications. However, perioperative risks remain unclear. This study evaluated the association between GLP-1RA use and postoperative complications in implant-based and autologous tissue breast reconstruction. Methods: A retrospective analysis of TriNetX identified patients undergoing implant-based or autologous tissue breast reconstruction. Preoperative GLP-1RA users were compared to matched controls. Patients were propensity score matched (1:1 and 1:3) for demographics and comorbidities including body-mass index and timing of reconstruction (delayed vs. immediate). Ninety-day outcomes were assessed using logistic regression. Results: Between 2014 and 2024, 57,987 patients were identified, of which 823 were GLP-1RA users. Of those users, 326 patients undergoing implant-based reconstruction and 51 patients undergoing autologous reconstruction were matched to controls. In implant-based cohorts, GLP-1RA use was associated with increased odds of implant failure (1:1 OR 1.70, 95% CI 1.18–2.45, p = 0.0046), wound healing complications (1:1 OR 1.90, p = 0.027), and higher readmission/ED utilization (1:1 OR 1.80, 95% CI 1.04–3.21, p = 0.040). No significant differences were observed for hematoma, seroma, or thromboembolism. In autologous reconstruction, GLP-1RA use was not associated with increased risks. Conclusions: GLP-1RA use is linked to higher rates of implant failure, wound healing complications, and readmission in implant-based breast reconstruction only. These findings highlight the need for risk stratification and counseling of GLP-1RA users undergoing implant-based procedures and for further research investigating the implications of perioperative use of these agents in plastic surgery.

Verified
Journal Article
Open access
PDF file
CKChristodoulos Kaoutzanis
Christodoulos Kaoutzanis
BHBilal F. Hamzeh
Bilal F. Hamzeh
MMMarkos Mardourian
Markos Mardourian
DMDavid Mathes
David Mathes
JWJulian Winocour
Julian Winocour
The deep inferior epigastric perforator (DIEP) flap holds its place as the gold standard approach for autologous tissue breast reconstruction given the strong durability, favorable donor site morbidity, and high patient satisfaction overall. With the reliability and safety of microsurgical reconstruction of the breasts being well-established over these last decades, the goals of DIEP flap reconstruction have expanded beyond flap survival toward optimization of aesthetic, patient-reported, and quality-of-life outcomes. Achieving ideal cosmesis requires thoughtful decision-making across the reconstructive continuum, including of radiation timing, mastectomy incision design, nipple–areolar complex management, reconstructive sequencing, flap shaping and inset, abdominal closure, neurotization, and the potential role of any revision or adjunctive procedures. Modern techniques including delayed-immediate reconstruction, nipple delay, free nipple grafting, fat grafting, and abdominal wall reinforcement have expanded the availability of personalized care in breast reconstruction. This narrative review integrates a targeted literature search with consensus-driven expert opinion informed by our senior authors’ extensive cumulative experience performing DIEP flap breast reconstruction. It discusses principles, technical strategies, and evolving evidence for optimizing aesthetic outcomes in DIEP flap breast reconstruction while preserving safety and minimizing morbidity.

18 June 2025 in The Journal of Physiology
Verified
Journal Article
Closed access
AWAaron Wang
Aaron Wang
RDRyan Dang
Ryan Dang
NCNicole Adara Case
Nicole Adara Case
BHBilal F. Hamzeh
Bilal F. Hamzeh